It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Michael Hengartner, chairman of the Novartis Venture Fund board

Prof Michael Hengartner


Michael Hengartner PhD, MBA is currently President of the ETH Board and Chairman of the Executive Committee of the ETH Domain. Prior to this appointment, he served as Rector of the University of Zurich (UZH) (2014 - 2020), and, from 2016 to 2020, he also served as President of swissuniversities. Michael studied Biochemistry at the Université Laval in Canada and, in 1994, was awarded his PhD at the Massachusetts Institute of Technology in the laboratory of Nobel Laureate H. Robert Horvitz. After that, he headed a research group at the Cold Spring Harbor Laboratory in the USA until 2001, when he was appointed to the newly established Ernst Hadorn Endowed Professorship at the Institute of Molecular Biology at the UZH. From 2009 to 2014, he was Dean of the Faculty of Mathematics and Natural Sciences of the UZH. Michael holds an Executive MBA from IMD, Lausanne and is the recipient of several awards for his research on the molecular basis of apoptosis, among them the Swiss National Latsis Prize, Josef Steiner Cancer Research Award, and an honorary doctorate from Sorbonne Université in Paris, France.